Understanding Your Child's Diagnosis: Cobblestone Lissencephaly
At a Glance
Cobblestone lissencephaly is a rare genetic condition where a developing baby's brain cells travel too far, creating an uneven, cobblestone-like brain surface. It is part of a spectrum of conditions called alpha-dystroglycanopathies, which often affect a child's brain, muscles, and eyes.
Receiving a diagnosis of cobblestone lissencephaly can feel like the world has shifted beneath your feet. It is a rare and complex condition, and the initial shock, fear, and uncertainty you are feeling are completely valid. While the road ahead will involve specialized care, understanding the “why” behind the diagnosis is the first step in finding your footing and becoming your child’s strongest advocate.
Understanding the “Cobblestone” Surface
The term “cobblestone” refers to the way the brain’s surface appears on an MRI scan [1]. To understand this, it helps to know how a brain typically develops. During pregnancy, young brain cells (neurons) travel from the center of the brain to their permanent homes on the outer layer, known as the cortex [1].
In children with cobblestone lissencephaly, these neurons do not stop where they are supposed to. Because the protective barrier that usually keeps them in place (the pial basement membrane) is weak or broken, the neurons “overmigrate,” or travel too far, spilling into the fluid-filled space around the brain [1][2]. This creates small clusters or bumps on the brain’s surface, giving it an uneven texture like a cobblestone street [1][3].
A Spectrum of Conditions
In the past, this was sometimes called Type II lissencephaly. Today, doctors recognize it as part of a group of genetic conditions called alpha-dystroglycanopathies [4][5]. This is a long name for a condition that affects how a specific protein (alpha-dystroglycan) helps “glue” cells into their proper places [5].
Because this protein is important for several parts of the body, cobblestone lissencephaly is often part of a broader syndrome that can affect:
- The Brain: The migration changes can cause severe developmental delays and, in many cases, epilepsy (seizures) [6][7].
- The Muscles: Many children have congenital muscular dystrophy, which means their muscles may be weak or have severely low tone (hypotonia) from birth [5][8].
- The Eyes: There may be severe structural changes in the eyes that affect vision [8][9].
The severity of these symptoms can vary widely depending on the specific gene involved [5][9]. You can read more about how this works on The Biology and Genetics page.
Stabilizing Facts for the Journey Ahead
While the diagnosis is serious, having clear information can help you focus on the next steps. Here are a few key facts to help ground you:
- You did not cause this. This condition is genetic, caused by specific changes in DNA. Specifically, it is typically an autosomal recessive condition [8]. This means both parents silently carry a single copy of the mutated gene without having any symptoms themselves. When both mutated copies are passed down (a 25% chance in each pregnancy), the child develops the condition [10][11]. Nothing you did or didn’t do during pregnancy caused the basement membrane to be weak.
- Every child is unique. While medical literature often focuses on the most severe cases (like Walker-Warburg Syndrome), there is a wide “spectrum” of severity [8][12]. Your child’s specific genetic makeup and brain structure will determine their own path [6].
- Proactive care matters. While the structure of the brain cannot be changed, the symptoms can be managed. Early intervention with physical, occupational, and speech therapies can help children reach their individual potential and improve their comfort [13].
- You are not alone. Because this is a known genetic spectrum, there are specialized clinics and support communities (like Cure CMD and dedicated parent groups) who are walking this same path and can offer invaluable wisdom.
What to Expect Next
Your medical team will likely include several specialists, such as a pediatric neurologist (brain doctor), a geneticist (DNA specialist), and an ophthalmologist (eye doctor) [8]. They will use tools like MRIs and genetic testing to get a clearer picture of your child’s needs [10][6]. While the initial days after a diagnosis are often overwhelming, the focus will gradually shift from “what happened” to “how we help your child thrive.” For more details on the specialists you will need, see the Standard of Care and Multidisciplinary Management page.
Common questions in this guide
What causes cobblestone lissencephaly?
What are the common symptoms of cobblestone lissencephaly?
What kinds of doctors will my child need to see?
Can cobblestone lissencephaly be treated?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Which specific gene (e.g., POMT1, FKTN, FKRP) is associated with my child's diagnosis, and what does that mean for their individual prognosis?
- 2.Has my child had a full evaluation of their eyes and muscles to look for other features of alpha-dystroglycanopathy?
- 3.What is the result of my child’s baseline EEG, and what signs of seizures should I be watching for at home?
- 4.Are there specific therapists (physical, occupational, or speech) who have experience with children who have severe neurological conditions?
- 5.Can you explain my child's MRI results? Specifically, which areas of the brain are most affected?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (13)
- 1
Cobblestone lissencephaly (Type II), clinical, and neuroimaging: A case report and literature review.
Sharma PK, Jerosha S, Subramonian SG, et al.
Radiology case reports 2024; (19(11)):4794-4803 doi:10.1016/j.radcr.2024.07.043.
PMID: 39228958 - 2
Ectopic clustering of Cajal-Retzius and subplate cells is an initial pathological feature in Pomgnt2-knockout mice, a model of dystroglycanopathy.
Nakagawa N, Yagi H, Kato K, et al.
Scientific reports 2015; (5()):11163 doi:10.1038/srep11163.
PMID: 26060116 - 3
Targeted deletion of RIC8A in mouse neural precursor cells interferes with the development of the brain, eyes, and muscles.
Kask K, Tikker L, Ruisu K, et al.
Developmental neurobiology 2018; (78(4)):374-390 doi:10.1002/dneu.22578.
PMID: 29380551 - 4
Evidence of early defects in Cajal-Retzius cell localization during brain development in a mouse model of dystroglycanopathy.
Booler HS, Pagalday-Vergara V, Williams JL, et al.
Neuropathology and applied neurobiology 2017; (43(4)):330-345 doi:10.1111/nan.12376.
PMID: 28039900 - 5
Biallelic Mutations in TMTC3, Encoding a Transmembrane and TPR-Containing Protein, Lead to Cobblestone Lissencephaly.
Jerber J, Zaki MS, Al-Aama JY, et al.
American journal of human genetics 2016; (99(5)):1181-1189 doi:10.1016/j.ajhg.2016.09.007.
PMID: 27773428 - 6
Comparison of brain MRI findings with language and motor function in the dystroglycanopathies.
Brun BN, Mockler SR, Laubscher KM, et al.
Neurology 2017; (88(7)):623-629 doi:10.1212/WNL.0000000000003609.
PMID: 28087826 - 7
Electrographic pattern recognition: A simple tool to predict clinical outcome in children with lissencephaly.
Jauhari P, Farmania R, Chakrabarty B, et al.
Seizure 2020; (83()):175-180 doi:10.1016/j.seizure.2020.10.020.
PMID: 33161247 - 8
A Successful Treatment of Endoscopic Third Ventriculostomy with Choroid Plexus Cauterization for Hydrocephalus in Walker-Warburg Syndrome.
Tanaka T, Harris CJ, Barnett SS, Litofsky NS
Case reports in neurological medicine 2016; (2016()):7627289 doi:10.1155/2016/7627289.
PMID: 28116189 - 9
Fetal Presentation of Walker-Warburg Syndrome with Compound Heterozygous POMT2 Missense Mutations.
Zago S, Silvestri E, Arcangeli T, et al.
Fetal and pediatric pathology 2023; (42(2)):334-341 doi:10.1080/15513815.2022.2116620.
PMID: 36048137 - 10
ISPD gene homozygous deletion identified by SNP array confirms prenatal manifestation of Walker-Warburg syndrome.
Trkova M, Krutilkova V, Smetanova D, et al.
European journal of medical genetics 2015; (58(8)):372-5.
PMID: 26087224 - 11
Dystroglycanopathies: About Numerous Genes Involved in Glycosylation of One Single Glycoprotein.
Bouchet-Séraphin C, Vuillaumier-Barrot S, Seta N
Journal of neuromuscular diseases 2015; (2(1)):27-38.
PMID: 28198708 - 12
Temporal requirement of dystroglycan glycosylation during brain development and rescue of severe cortical dysplasia via gene delivery in the fetal stage.
Sudo A, Kanagawa M, Kondo M, et al.
Human molecular genetics 2018; (27(7)):1174-1185 doi:10.1093/hmg/ddy032.
PMID: 29360985 - 13
Postnatal Gene Therapy Improves Spatial Learning Despite the Presence of Neuronal Ectopia in a Model of Neuronal Migration Disorder.
Hu H, Liu Y, Bampoe K, et al.
Genes 2016; (7(12)).
PMID: 27916859
This guide provides general educational information about cobblestone lissencephaly for parents and caregivers. Always consult your child's pediatric neurologist and medical team for specific diagnostic interpretation and care recommendations.
Get notified when new evidence is published on Cobblestone lissencephaly.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.